ONCOBIOPHARM LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- 1 Lochrin Square 92-98 Fountainbridge Edinburgh Scotland EH3 9QA Copied!
Latest financial results as of 2 August 2025- Cash in bank
- £4.45k
- Current assets
- £143.36k
- Fixed assets
- £180.07k
- Current creditors
- £62.34k
- Shareholders funds
- £3.16m
View full financial accounts- Cash in bank
- £4.45k
- Current assets
- £143.36k
- Fixed assets
- £180.07k
- Current creditors
- £62.34k
- Shareholders funds
- £3.16m
- Company number
- SC288225 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2025
Confirmation statement
Latest confirmation statement statement dated 29 July 2024
Next statement due by 12 August 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| DUNWILCO (1277) LIMITED | 14 October 2005 |
| NUCANA LIMITED | 2 November 2006 |
| NUCANA BIOPHARMACEUTICALS LIMITED | 2 July 2008 |
Latest company documents
| Date | Description |
|---|---|
| 23/06/2523 June 2025 New | Total exemption full accounts made up to 2024-09-30 |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 09/08/249 August 2024 | Confirmation statement made on 2024-07-29 with no updates |
| 01/08/241 August 2024 | Director's details changed for Mr Wilfred Sydney Hanna on 2024-07-22 |
| 25/06/2425 June 2024 | Total exemption full accounts made up to 2023-09-30 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company